Overview Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability Status: Completed Trial end date: 2015-07-01 Target enrollment: Participant gender: Summary Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability Phase: Phase 1 Details Lead Sponsor: AstraZeneca